ITGAE and neoplasm: demonstrated that Treg specific ablation of the IL-33 receptor ST2 diminished the KLRG1+CD103+ Tregs, induced CD8+ T cell infiltration, and reduced the tumor burden, highlighting the dominant immunosuppressive and tumor promoting characteristics of this Treg subpopulation in lung cancer (92).